Involvement of amlodipine, diazoxide, and glibenclamide in development of morphine tolerance in mice

Omid Khalilzadeh1, Mehdi Anvari, Azita Khalilzadeh

  • 1Department of Pharmacology and Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.

Insights

This study investigated how calcium and potassium channel modulators affect morphine tolerance. Amlodipine and diazoxide worsened morphine tolerance, while glibenclamide reduced it, suggesting channel involvement in opioid tolerance.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Management

Background:

  • Opioid tolerance, a common issue in pain management, necessitates understanding its underlying mechanisms.
  • Calcium and potassium channels are implicated in neuronal excitability and drug action.

Purpose of the Study:

  • To investigate the role of calcium and potassium channels in the development of morphine-induced tolerance.
  • To examine the effects of amlodipine, diazoxide, and glibenclamide on morphine tolerance in a preclinical pain model.

Main Methods:

  • The study utilized the formalin test to assess pain and tolerance.
  • Morphine was administered intraperitoneally (i.p.) in combination with varying doses of amlodipine, diazoxide, or glibenclamide.
  • Behavioral responses were measured in the first and second phases of the formalin test.

Main Results:

  • Co-administration of amlodipine (5-10 mg/kg) or diazoxide (1-10 mg/kg) with morphine potentiated morphine tolerance in both phases of the formalin test.
  • Glibenclamide (2.5-10 mg/kg) significantly decreased morphine tolerance in the second phase of the formalin test.

Conclusions:

  • Calcium channel blockade (amlodipine) and potassium channel opening (diazoxide) appear to enhance morphine tolerance.
  • Potassium channel blockade (glibenclamide) may attenuate morphine tolerance, particularly in later stages.
  • These findings suggest that calcium and potassium channel modulations are involved in the development of morphine tolerance.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...